Bill
Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug…
Overview and Timeline are the same for every version. Text and Votes below change with the version you select.
Introduced in Senate — Mar 3, 2025
This Act may be cited as the “Ensuring Pathways to Innovative Cures Act of 2025” or the “EPIC Act of 2025”.
Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended—
(1)
by striking “year, at least 7” and inserting “year—
(I)
for initial price applicability years 2026 and 2027, at least 7
(2)
by adding at the end the following:
(II)
for initial price applicability year 2028 and each subsequent initial price applicability year, at least 11 years will have elapsed since the date of such approval; and